Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
21 Apr 2023
Historique:
received: 15 10 2022
accepted: 19 01 2023
medline: 24 4 2023
pubmed: 21 4 2023
entrez: 21 04 2023
Statut: epublish

Résumé

Chronic pruritus is a prevalent interdisciplinary symptom with a strong influence on health-related quality of life. Patients need extensive diagnostics and long-term treatment. This retrospective and prospective cohort study compared routine and university-based specialized care in terms of cost-effectiveness and patient benefit. Direct medical and non-medical costs and patient-reported outcomes (PRO; pruritus intensity, quality of life, treatment needs and benefits) were assessed. Data analyses were conducted using descriptive methods and non-parametric statistical tests. A total of 300 adult patients (54.3% female) participated in the study. Six months after the treatment start in a specialized German pruritus care unit, the total costs were significantly reduced (mean total costs 686 € vs 433 € per patient per half year (total cohort); p <  0.001; mean out-of-pocket costs 198 € vs 124 € per half year (total cohort), p <  0.001). Pruritus intensity (numerical rating  scale 5.3 vs 3.7, p < 0.001), quality of life (Dermatology Life Quality Index 8.9 vs 5.7, p < 0.001) and patient benefit (Patient Benefit Index Pruritus 1.2 vs 2.1, p < 0.001) improved significantly (total  cohort). The results of this study show, that treatment of chronic pruritus patients in a specialized itch centre leads to an improvement in patient  benefit and reduces the economic burden at the same time.

Identifiants

pubmed: 37083094
doi: 10.2340/actadv.v103.4868
pmc: PMC10134063
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv4868

Références

Dermatology. 2006;212(2):137-44
pubmed: 16484820
Acta Derm Venereol. 2019 Apr 1;99(5):469-506
pubmed: 30931482
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):738-743
pubmed: 32924186
Itch (Phila). 2017 Sep;2(2):e6
pubmed: 30828641
Methods Inf Med. 2018 Dec;57(S 02):e107-e114
pubmed: 30453339
Eur Spine J. 2018 Nov;27(11):2875-2881
pubmed: 30155730
Br J Dermatol. 2009 Nov;161(5):1143-8
pubmed: 19857211
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):174-180
pubmed: 28857297
Acta Orthop. 2005 Apr;76(2):275-84
pubmed: 16097556
PLoS One. 2013 Oct 23;8(10):e78152
pubmed: 24194911
Acta Derm Venereol. 2016 Nov 2;96(7):978-980
pubmed: 27068455
Expert Opin Pharmacother. 2016;17(5):671-87
pubmed: 26630350
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1921-1927
pubmed: 30887577
Dermatology. 2010;221(3):229-35
pubmed: 20924157
Acta Derm Venereol. 2019 Feb 1;99(2):211-217
pubmed: 30307024
PLoS One. 2020 Mar 3;15(3):e0229228
pubmed: 32126108
Hautarzt. 2016 Aug;67(8):640-7
pubmed: 27316924
Acta Derm Venereol. 2018 Jan 12;98(1):38-43
pubmed: 28929169
Acta Med Port. 2019 Apr 30;32(4):272-278
pubmed: 31067421
Medicines (Basel). 2019 Aug 11;6(3):
pubmed: 31405223
Expert Opin Biol Ther. 2022 Jan;22(1):47-58
pubmed: 34289753
J Invest Dermatol. 2020 Mar;140(3):699-701.e5
pubmed: 31465742
Br J Dermatol. 2017 Feb;176(2):363-370
pubmed: 27479717
J Invest Dermatol. 2017 Jul;137(7):1461-1467
pubmed: 28259687
J Am Acad Dermatol. 2019 Mar;80(3):810-813
pubmed: 30365994
Acta Derm Venereol. 2013 Sep 4;93(5):562-8
pubmed: 23494363
Acta Derm Venereol. 2015 Mar;95(3):266-71
pubmed: 25136974
Eur J Public Health. 2008 Feb;18(1):85-91
pubmed: 17569699
PLoS One. 2019 Jul 10;14(7):e0210917
pubmed: 31291250
Acta Derm Venereol. 2016 Jan;96(1):50-5
pubmed: 26067841
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1346-1356
pubmed: 33651457
Acta Derm Venereol. 2016 Mar;96(3):361-6
pubmed: 26551638
J Am Acad Dermatol. 2018 Sep;79(3):457-463.e5
pubmed: 30119869
Spine (Phila Pa 1976). 1995 Aug 1;20(15):1668-73
pubmed: 7482015
Acta Derm Venereol. 2020 Jan 17;100(4):adv00068
pubmed: 31950196
J Am Acad Dermatol. 2017 May;76(5):958-972.e2
pubmed: 28259441
J Dtsch Dermatol Ges. 2015 Feb;13(2):101-15; quiz 116
pubmed: 25631127
Contact Dermatitis. 2013 Aug;69(2):99-106
pubmed: 23869729
Dermatology. 2015;230(1):27-33
pubmed: 25613671

Auteurs

Svenja Müller (S)

Department of Dermatology and Allergy; University Hospital Bonn, Bonn, Germany. svenja2.mueller@ukbonn.de.

Sonja Ständer (S)

Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Germany.

Mandy Naatz (M)

German Center for Health Services Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf (UKE), Germany.

Matthias Augustin (M)

German Center for Health Services Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf (UKE), Germany.

Sabine Steinke (S)

Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Germany; Bielefeld University, Medical School OWL, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH